Two Seas Capital LP cut its stake in shares of Indivior PLC (NASDAQ:INDV - Free Report) by 4.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 12,457,514 shares of the company's stock after selling 572,513 shares during the period. Indivior accounts for approximately 12.2% of Two Seas Capital LP's portfolio, making the stock its 2nd largest holding. Two Seas Capital LP owned approximately 9.04% of Indivior worth $154,847,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also recently modified their holdings of INDV. Claret Asset Management Corp bought a new position in Indivior in the 4th quarter worth about $9,304,000. CenterBook Partners LP raised its holdings in shares of Indivior by 105.5% during the 4th quarter. CenterBook Partners LP now owns 1,147,841 shares of the company's stock valued at $14,268,000 after buying an additional 589,158 shares in the last quarter. Marshall Wace LLP grew its holdings in shares of Indivior by 659.7% during the 4th quarter. Marshall Wace LLP now owns 506,782 shares of the company's stock valued at $6,299,000 after purchasing an additional 440,072 shares during the last quarter. SIH Partners LLLP bought a new stake in shares of Indivior in the 4th quarter valued at about $2,698,000. Finally, Kazazian Asset Management LLC purchased a new stake in shares of Indivior during the fourth quarter valued at approximately $1,706,000. 60.33% of the stock is owned by hedge funds and other institutional investors.
Indivior Stock Up 0.4%
Shares of NASDAQ:INDV traded up $0.05 during midday trading on Monday, reaching $11.26. The company's stock had a trading volume of 1,303,351 shares, compared to its average volume of 1,022,970. The firm has a 50 day moving average of $10.30 and a 200-day moving average of $10.71. The firm has a market capitalization of $1.55 billion, a P/E ratio of -32.17 and a beta of 0.98. Indivior PLC has a 12-month low of $7.33 and a 12-month high of $18.59.
Indivior (NASDAQ:INDV - Get Free Report) last announced its earnings results on Thursday, April 24th. The company reported $0.41 earnings per share for the quarter, beating analysts' consensus estimates of $0.22 by $0.19. Indivior had a negative net margin of 3.96% and a negative return on equity of 241.73%. The business had revenue of $266.00 million during the quarter, compared to the consensus estimate of $240.13 million. On average, research analysts predict that Indivior PLC will post 1.22 EPS for the current year.
Analyst Ratings Changes
A number of equities research analysts have issued reports on INDV shares. RODMAN&RENSHAW raised shares of Indivior to a "strong-buy" rating in a report on Tuesday, January 28th. Piper Sandler lowered their price target on Indivior from $16.00 to $13.00 and set an "overweight" rating for the company in a research report on Thursday, March 6th. Finally, Rodman & Renshaw initiated coverage on Indivior in a report on Tuesday, January 28th. They issued a "buy" rating and a $16.00 price objective for the company.
Read Our Latest Research Report on INDV
About Indivior
(
Free Report)
Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.
Featured Articles

Before you consider Indivior, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Indivior wasn't on the list.
While Indivior currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.